The Expression and Contribution of SRCs with Preeclampsia Placenta

Area of Science:

• Endocrinology
• Reproductive Biology
• Pathology

Background:

• Steroid hormones mediate cellular functions via receptor binding and coactivator interaction.
• The p160 steroid receptor coactivator (SRC) family are key regulators of steroid hormone signaling.
• SRC family functions are well-studied in most organs but underexplored in the placenta, particularly concerning preeclampsia (PE).

Purpose of the Study:

• To compare SRC expression patterns in normal versus PE human placentas.
• To investigate SRC expression in PE-relevant conditions, including a rat model and hypoxic placental cells.
• To examine the interaction between estrogen receptors (ERs) and SRC-1 in normal and PE placentas.

Main Methods:

• Quantitative analysis of SRC-1 mRNA and protein levels in human placental tissues.
• Utilized the Reduced Uterine Perfusion Pressure (RUPP) rat model to mimic PE.
• Cultured placental cells under hypoxic conditions.
• Performed co-immunoprecipitation to assess ER-SRC-1 interactions.

Main Results:

• SRC-1 mRNA and protein levels were significantly downregulated in human PE placentas compared to normal controls.
• SRC-1 protein levels were reduced in the RUPP rat model placenta and in placental cells cultured under hypoxia.
• Co-immunoprecipitation revealed stronger interactions between ERα/ERβ and SRC-1 in PE placentas than in normal placentas.

Conclusions:

• SRC-1, but not SRC-2 or SRC-3, expression is decreased in hypoxia-induced PE placentas.
• Reduced SRC-1 may impair estradiol signaling, potentially contributing to PE pathogenesis.
• Dysregulated SRC-1 signaling is associated with placental symptoms observed in PE patients.